Skip to content
1st Counsel – Lifestyle
Author:
Endogenex
Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval
March 25, 2026
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
March 17, 2026